Company / Shares Outstanding
Charles River Laboratories Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
49.2M
FY2025
5-year range
49.2M / 51.3M
FY2021-FY2025
Trend
-4.1%
vs FY2024
Sector context
#119 of 165
Health Care
What the data says
At 49217000.00, Charles River Laboratories's shares outstanding ranks #47 of 165 in the Health Care sector. Shares Outstanding remained relatively stable over the past 10 years, with values between 46698000.00 and 51338000.00.
Based on SEC 10-K filings.
49217000.00 in FY2025 with a 5-year CAGR of +0.1%.
Improved from 50944000.00 to 49217000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -0.8%
- 5-Year CAGR
- +0.1%
- 10-Year CAGR
- -
Sector benchmark
#47 of 165 in Health CareTop 28% of 165This company 49.2M Sector average 171.0M
▼
-71.2% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding decreased 4.1% year-over-year.
- Ranks #119 out of 165 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2024.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 49.2M | -4.1% |
| FY2024 | 51.3M | +0.8% |
| FY2023 | 50.9M | +0.9% |
| FY2022 | 50.5M | +1.4% |
| FY2021 | 49.8M | +1.7% |
| FY2020 | 48.9M | +1.5% |
| FY2019 | 48.2M | +1.7% |
| FY2018 | 47.4M | +0.1% |
| FY2017 | 47.4M | +1.4% |
| FY2016 | 46.7M | -1.3% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026